Skip to main content
. Author manuscript; available in PMC: 2023 Dec 11.
Published in final edited form as: N Engl J Med. 2023 Mar 27;388(23):2159–2170. doi: 10.1056/NEJMoa2302312

Figure 1. Enrollment and Outcomes.

Figure 1.

The patients were stratified into two cohorts according to whether they had mismatch repair–deficient (dMMR) or mismatch repair–proficient (pMMR) disease on immunohistochemical (IHC) assessment.